Clinical Trial Update: A Study of AB801 Monotherapy and Combination Therapy in Participants With Advanced Malignancies [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study of AB801 as both monotherapy and in combination therapy for advanced cancers, which is currently active but…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• AB801

Snippet

Sponsor: Arcus Biosciences, Inc. | Conditions: Advanced Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING